OPSUMIT
Traitement à long terme de l’hypertension artérielle pulmonaire (HTAP) chez les patients en classes fonctionnelles …
Additional information from the official database
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
FTAB
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
38.86 MG | Substance | HBESI |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
0.21 MG | Substance | HBESI |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | FNIDK |
4123 Allschwil